JPM Stock Spotlight: Mereo BioPharma Holds Steady Ahead of JPM Healthcare Conference
Biotech stocks often pause before big industry events. That is exactly what is happening with Mereo BioPharma. As of January 2026, Mereo BioPharma shares are trading in a narrow range, following weeks of sharp moves and heavy investor debate. The timing is not random. The global biotech spotlight is shifting toward the J.P. Morgan Healthcare Conference, one of the most market-moving events of the year.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
